BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29485201)

  • 21. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
    Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Nagel G; Linseisen J; Boshuizen HC; Pera G; Del Giudice G; Westert GP; Bueno-de-Mesquita HB; Allen NE; Key TJ; Numans ME; Peeters PH; Sieri S; Siman H; Berglund G; Hallmans G; Stenling R; Martinez C; Arriola L; Barricarte A; Chirlaque MD; Quiros JR; Vineis P; Masala G; Palli D; Panico S; Tumino R; Bingham S; Boeing H; Bergmann MM; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Olsen A; Tjonneland A; Trichopoulou A; Bamia C; Soukara S; Sabourin JC; Carneiro F; Slimani N; Jenab M; Norat T; Riboli E; González CA
    Int J Epidemiol; 2007 Feb; 36(1):66-76. PubMed ID: 17227779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary intake of lignans and risk of esophageal and gastric adenocarcinoma: a cohort study in Sweden.
    Lin Y; Wolk A; Håkansson N; Lagergren J; Lu Y
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):308-12. PubMed ID: 23195991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers.
    Murphy G; Abnet CC; Choo-Wosoba H; Vogtmann E; Weinstein SJ; Taylor PR; Männistö S; Albanes D; Dawsey SM; Rehfeld JF; Freedman ND
    Int J Epidemiol; 2017 Jun; 46(3):914-923. PubMed ID: 28369403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
    Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
    Ljung R; Martin L; Lagergren J
    Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China.
    Abnet CC; Qiao YL; Dawsey SM; Buckman DW; Yang CS; Blot WJ; Dong ZW; Taylor PR; Mark SD
    Cancer Causes Control; 2003 Sep; 14(7):645-55. PubMed ID: 14575362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intake.
    Vingeliene S; Chan DS; Aune D; Vieira AR; Polemiti E; Stevens C; Abar L; Rosenblatt DN; Greenwood DC; Norat T
    Cancer Causes Control; 2016 Jul; 27(7):837-51. PubMed ID: 27153845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Mc Menamin ÚC; Kunzmann AT; Cook MB; Johnston BT; Murray LJ; Spence AD; Cantwell MM; Cardwell CR
    Int J Cancer; 2018 Aug; 143(4):831-841. PubMed ID: 29532460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.
    Chow WH; Blot WJ; Vaughan TL; Risch HA; Gammon MD; Stanford JL; Dubrow R; Schoenberg JB; Mayne ST; Farrow DC; Ahsan H; West AB; Rotterdam H; Niwa S; Fraumeni JF
    J Natl Cancer Inst; 1998 Jan; 90(2):150-5. PubMed ID: 9450576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Lindblad M; Lagergren J; García Rodríguez LA
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):444-50. PubMed ID: 15734971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden.
    Bahmanyar S; Ye W
    Nutr Cancer; 2006; 54(2):171-8. PubMed ID: 16898861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
    Wu AH; Tseng CC; Bernstein L
    Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cancer survival and ambient ultraviolet B irradiance in China.
    Chen W; Armstrong BK; Rahman B; Zheng R; Zhang S; Clements M
    Cancer Causes Control; 2013 Jul; 24(7):1323-30. PubMed ID: 23568535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes.
    Freedman ND; Abnet CC; Leitzmann MF; Mouw T; Subar AF; Hollenbeck AR; Schatzkin A
    Am J Epidemiol; 2007 Jun; 165(12):1424-33. PubMed ID: 17420181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study.
    Busby J; Karasneh R; Murchie P; McMenamin Ú; Gadalla SM; Camargo MC; Iversen L; Lee AJ; Spence AD; Cardwell CR
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):48-56. PubMed ID: 31713940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.
    Thrift AP; Kramer JR; Hartman CM; Royse K; Richardson P; Dong Y; Raychaudhury S; Desiderio R; Sanchez D; Anandasabapathy S; White DL; Chiao EY
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e65-e72. PubMed ID: 30939533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study.
    Ness-Jensen E; Bringeland EA; Mattsson F; Mjønes P; Lagergren J; Grønbech JE; Waldum HL; Fossmark R
    Int J Cancer; 2021 Apr; 148(8):1879-1886. PubMed ID: 33091962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.